| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 2.714 | 20.343 | 21.424 | 26.016 | 19.834 | 17.092 |
| Total Income - EUR | - | - | - | 0 | 2.714 | 20.343 | 21.424 | 26.016 | 19.834 | 17.092 |
| Total Expenses - EUR | - | - | - | 82 | 2.257 | 10.369 | 6.659 | 17.960 | 19.841 | 18.386 |
| Gross Profit/Loss - EUR | - | - | - | -82 | 457 | 9.974 | 14.765 | 8.056 | -6 | -1.294 |
| Net Profit/Loss - EUR | - | - | - | -82 | 376 | 9.402 | 14.199 | 7.291 | -6 | -1.294 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Brodent Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 16 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 43 | 1.204 | 9.978 | 23.909 | 7.724 | 8.559 | 7.567 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 62 | 63 | 908 | 1.364 | 564 | 560 |
| Cash | - | - | - | 43 | 1.142 | 9.915 | 23.001 | 6.360 | 7.995 | 7.007 |
| Shareholders Funds | - | - | - | -39 | 337 | 9.733 | 23.716 | 7.340 | 6.721 | 5.390 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 98 | 867 | 245 | 193 | 384 | 1.838 | 2.178 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Brodent Clinique S.r.l.